Literature DB >> 18484318

Costing adult male circumcision in high HIV prevalence, low circumcision rate countries.

John Vincent Fieno1.   

Abstract

The dramatic evidence that male circumcision has a substantial effect in preventing HIV infection might be the most important medical finding in the course of the AIDS epidemic since the introduction of highly active antiretroviral therapy (HAART). The transition from clinical trails to implementation of a general adult male circumcision (AMC) program is beginning, and this paper uses an AMC cost model (in Microsoft Excel) to estimate the cost of a rapid scale-up of an AMC program in Mozambique, a country with a generalized epidemic and low rate of male circumcision. There are three major findings: (1) Even the most modest of AMC programs would place great stress on human resources, and task-shifting might lead to more accidents or adverse events that would increase the cost per AMC. (2) The fiscal burden of AMC is surprisingly low, but a rapid scale-up of AMC poses additional fiscal stress for Mozambique's already under-funded public health system. (3) AMC as an HIV prevention tool is very robust in terms of its cost-effectiveness in Mozambique, even at a high AMC accident or complication rate. Any AMC roll-out in Mozambique would face severe constraints in the health system (namely human resources) that would likely limit the scale of an AMC program and perhaps its effectiveness against its generalized epidemic.

Entities:  

Mesh:

Year:  2008        PMID: 18484318     DOI: 10.1080/09540120701867149

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  11 in total

1.  Cost-effectiveness of surgery in low- and middle-income countries: a systematic review.

Authors:  Caris E Grimes; Jaymie Ang Henry; Jane Maraka; Nyengo C Mkandawire; Michael Cotton
Journal:  World J Surg       Date:  2014-01       Impact factor: 3.352

2.  Does Routine Pathology Analysis of Adult Circumcision Tissue Identify Penile Cancer?

Authors:  Viral S Shah; Nathan L Jung; Daniel K Lee; Kenneth G Nepple
Journal:  Urology       Date:  2015-04-11       Impact factor: 2.649

Review 3.  Male circumcision and HIV infection risk.

Authors:  John N Krieger
Journal:  World J Urol       Date:  2011-05-18       Impact factor: 4.226

Review 4.  Economic evaluations of adult male circumcision for prevention of heterosexual acquisition of HIV in men in sub-Saharan Africa: a systematic review.

Authors:  Olalekan A Uthman; Taiwo Aderemi Popoola; Mubashir M B Uthman; Olatunde Aremu
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

5.  Trends in the Marginal Cost of Male Circumcision in Rural Rakai Uganda.

Authors:  Yira N Alfonso; David Bishai; Agnes Nantongo; Rebecca Kakembo; Sarah Kobusinge; Seema Kacker; Godfrey Kigozi; Ronald Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2016-12-15       Impact factor: 3.731

6.  Voluntary medical male circumcision: a qualitative study exploring the challenges of costing demand creation in eastern and southern Africa.

Authors:  Jane T Bertrand; Emmanuel Njeuhmeli; Steven Forsythe; Sarah K Mattison; Hally Mahler; Catherine A Hankins
Journal:  PLoS One       Date:  2011-11-29       Impact factor: 3.240

Review 7.  Male circumcision for HIV prevention in high HIV prevalence settings: what can mathematical modelling contribute to informed decision making?

Authors: 
Journal:  PLoS Med       Date:  2009-09-08       Impact factor: 11.069

8.  Can we spend our way out of the AIDS epidemic? A world halting AIDS model.

Authors:  Robert J Smith; Jing Li; Richard Gordon; Jane M Heffernan
Journal:  BMC Public Health       Date:  2009-11-18       Impact factor: 3.295

9.  Health and economic benefits of improved injury prevention and trauma care worldwide.

Authors:  Meera Kotagal; Kiran J Agarwal-Harding; Charles Mock; Robert Quansah; Carlos Arreola-Risa; John G Meara
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  HIV prevention costs and their predictors: evidence from the ORPHEA Project in Kenya.

Authors:  Omar Galárraga; Richard G Wamai; Sandra G Sosa-Rubí; Mercy G Mugo; David Contreras-Loya; Sergio Bautista-Arredondo; Helen Nyakundi; Joseph K Wang'ombe
Journal:  Health Policy Plan       Date:  2017-12-01       Impact factor: 3.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.